Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024
2024年10月23日 - 8:30PM
Emergent BioSolutions Inc. (NYSE: EBS) will host a conference
call on Wednesday, November 6, 2024, at 5:00 pm eastern
time to discuss the financial results for the third quarter of
2024, recent business developments, and financial outlook for full
year 2024.
Webcast & Conference Call
InformationParticipants can access the conference call
live via webcast. To join via telephone, please use the following
dial-in details:
- U.S. / New York: +1-646-968-2525
- U.S. & Canada (Toll Free): +1-888-596-4144
- Conference ID: 5259189
A replay of the call can be accessed from the Investors page of
Emergent’s website.
About Emergent BioSolutionsAt Emergent, our
mission is to protect and enhance life. For 25 years, we’ve been at
work defending people from things we hope will never happen—so we
are prepared just in case they ever do. We provide solutions for
complex and urgent public health threats through a portfolio of
vaccines and therapeutics that we develop and manufacture for
governments and consumers. We also offer a range of integrated
contract development and manufacturing services for pharmaceutical
and biotechnology customers. To learn more about how we plan to
protect or enhance 1 billion lives by 2030, visit
our website and follow us
on LinkedIn, X, Instagram, Apple
Podcasts and Spotify.
Investor Contact:Richard S.
LindahlExecutive Vice President, CFOlindahlr@ebsi.com
Media Contact:Assal HellmerVice
President, Communicationsmediarelations@ebsi.com
Emergent Biosolutions (NYSE:EBS)
過去 株価チャート
から 9 2024 まで 10 2024
Emergent Biosolutions (NYSE:EBS)
過去 株価チャート
から 10 2023 まで 10 2024
